Renowned Geneticist Philip Beales Launches Axovia Therapeutics to Develop Transformative Medicines for Ciliopathies
February 25, 2021 07:00 ET
|
Axovia Therapeutics
Axovia is focused on developing transformative gene therapies for cilia disorders, starting with Bardet-Biedl SyndromeAxovia is a majority-owned subsidiary of Jaguar Gene Therapy, which is backed by...